Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Efficacy and safety of pioglitazone/metformin fixed-dose combination therapy compared with pioglitazone and metformin monotherapy in treating patients with T2DM
Current Medical Research and Opinion, 10/22/09
Perez A et al. – Overall, treatment with pioglitazone/metformin FDC demonstrated greater efficacy than its individual components. The FDC therapy was well tolerated, with reduced or similar adverse event rates compared with each individual monotherapy.
Related Articles
Pioglitazone Compared with Metformin Increases Pericardial Fat Volume in Patients with Type 2 Diabetes Mellitus
Journal of Clinical Endocrinology and Metabolism, 11/17/09
Relevance Score: 96%
Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 96%
Lactic Acidosis Associated With Metformin in a Patient With Type 2 Diabetes With No Contraindication
The Endocrinologist, 11/13/09
Relevance Score: 94%
Long-term effects of pioglitazone in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity
Current Medical Research and Opinion, 10/19/09
Relevance Score: 94%
Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes
Evidence-Based Medicine, 10/07/09
Relevance Score: 94%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Metformin increases plasma ghrelin in Type 2 diabetes
British Journal of Clinical Pharmacology, 12/11/09
Diabetic nephropathy: which teenagers are at risk and how can risk be minimised
Paediatrics and Child Health, 12/11/09
Prepregnancy Overweight and Gestational Diabetes as Determinants of Subsequent Diabetes and Hypertension after 20-Year Follow-Up
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Year Two Assessment of Fenofibric Acid and Moderate-Dose Statin Combination: A Phase 3, Open-Label, Extension Study
Clinical Drug Investigation, 12/11/09
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin
Journal of Clinical Endocrinology and Metabolism, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


